Lorenzo Fuccio, Vincenzo Cennamo. Show Affiliations »
Abstract
Entities: Chemical
Mesh： See more » Angiogenesis Inhibitors/administration & dosageAngiogenesis Inhibitors/adverse effectsAntibodies, Monoclonal/administration & dosageAntibodies, Monoclonal/adverse effectsAntibodies, Monoclonal, HumanizedAntineoplastic Combined Chemotherapy Protocols/adverse effectsAntineoplastic Combined Chemotherapy Protocols/therapeutic useBevacizumabCapecitabineColonic Diseases/chemically inducedColonic Diseases/therapyColorectal Neoplasms/therapyDeoxycytidine/administration & dosageDeoxycytidine/adverse effectsDeoxycytidine/analogs & derivativesDrug-Related Side Effects and Adverse ReactionsFluorouracil/administration & dosageFluorouracil/adverse effectsFluorouracil/analogs & derivativesHumansIntestinal Obstruction/therapyIntestinal Perforation/chemically inducedOrganoplatinum Compounds/administration & dosageOrganoplatinum Compounds/adverse effectsOxaliplatinRupture, SpontaneousStents
Substances： See more » Angiogenesis InhibitorsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedOrganoplatinum CompoundsOxaliplatinDeoxycytidineBevacizumabCapecitabineFluorouracil
Year: 2010 PMID： 21111886 DOI： 10.1016/j.gie.2010.03.1073
Source DB: PubMed Journal: Gastrointest Endosc ISSN： 0016-5107 Impact factor: 9.427